Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_assertion type Assertion NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_head.
- NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_assertion description "[Homozygosity for the complement factor H Y402H polymorphism, which is thought to reduce complement inhibition, was associated with less frequent SIRS/sepsis (the adjusted odds ratio for the homozygous variant complement factor H Y402H [CC] carriers was 0.3, 95% confidence interval, 0.1-0.7, p = .005).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_provenance.
- NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_assertion evidence source_evidence_literature NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_provenance.
- NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_assertion SIO_000772 20351616 NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_provenance.
- NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_assertion wasDerivedFrom befree-20140225 NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_provenance.
- NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_assertion wasGeneratedBy ECO_0000203 NP453640.RA87Mq6rRNT-6X6A-0AULFc59ryn00n96mhH8vIQOVNgU130_provenance.